LIPTA

LIPTA

DCI : AMLODIPINE+ATORVASTATIN

Dosage 10 mg/10 mg
Pharmaceutical form Coated tablet
Therapeutic class Cardiology-Engiology
B/30
Indications

This medication is indicated for the prevention of cardiovascular events for hypertensive patients with 3 associated cardiovascular risk factors, with normal to moderately high cholesterol without proven coronary disease, and in whom, according to the recommendations in force, the concomitant use of amlodipine and a low dose of atorvastatin is suitable. This medication should be used when the response to diet and other non-pharmacological measures is inadequate.

Download the leaflet

Similar Products

AMLODIS 
AMLODIS 
AMLODIS 
AMLODIS 
AMLODIS 
AMLODIS 
AMLODIS 
AMLODIS 
APROFORT
APROFORT
APROFORT
APROFORT
APROFORT
APROFORT
APROZAR 
APROZAR 
APROZAR 
APROZAR 
APROZAR
APROZAR
APROZAR
APROZAR
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
COAPROZAR 
CORAPRIL 
CORAPRIL 
CORAPRIL 
CORAPRIL 
CORAPRIL
CORAPRIL
COTAREG 
COTAREG 
COTAREG 
COTAREG 
COTAREG
COTAREG
DAFLON
DAFLON
FLUDEX LP
FLUDEX LP
LIPTA
LIPTA
LOXEN LP
LOXEN LP
NEBILUS 
NEBILUS 
NEBILUS 
NEBILUS 
RAPRIL 
RAPRIL 
RAPRIL 
RAPRIL 
TAREG 80 
TAREG 80 
TAREG 160 
TAREG 160 
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
TAVASTOR
VASTAREL
VASTAREL